NCT02447900View on ClinicalTrials.gov

Marker Guided Breathhold Radiotherapy in NSCLC

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Non-Small Cell Lung Cancer
Interventions
DEVICE

BioXmark

Trial Locations (1)

Unknown

Rigshospitalet, Denmark, Copenhagen

All Listed Sponsors
lead

Steen Riisgaard Mortensen

OTHER

NCT02447900 - Marker Guided Breathhold Radiotherapy in NSCLC | Biotech Hunter | Biotech Hunter